Use access key #2 to skip to page content.
$5.64 -0.07 (-1.23%)
9/5/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

2

Avatar spinbob7 (66.74) Submitted: 6/16/06 12:08 AM : Outperform Start Price: $10.56 EXEL Score: -45.92

Very deep pipeline and good partnerships will allow this young biotech to bring numerous drugs to market beginning around 2010.

Report this Post Replies: 1 | Reply

Avatar Bluerose113 (< 20) Submitted: 8/30/06 12:47 PM

Recs: 0 | Rec This

That is the same buzz I heard. I am always hopeful for the small companies working hard to make a mark. They seem to be on the right track.

Report this Post Reply

Featured Broker Partners